Latest News & Features
Patents
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid. 29 October 2024
Patents
Patents are key to ensuring continued investment in pharma R&D.
What are the unique patent considerations for pharma/biotech patents and AI patents in Europe? 29 October 2024
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field. 29 October 2024
Patents
There is an intricate intersection between patenting and clinical trials within the dynamic IP landscape in the life sciences industries. Safeguarding your innovation throughout the research process is critical, necessitating a careful balance between the need to file and when to file. 29 October 2024
Patents
Join us as we delve into the complexities of international harmonization and global patent strategies in the ever-evolving landscape of IP rights. 29 October 2024
Patents
The Unified Patent Court (UPC) opened for business in June 2023. In this session, we will look at how UPC litigation has been shaping up over the last year, including practical tips based on our experiences so far. 29 October 2024
Patents
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing. 29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. 29 October 2024
Patents
In today's global marketplace, intellectual property (IP) rights are not merely legal tools but strategic assets that can significantly influence a product's lifecycle, from development to market. 29 October 2024
Patents
Machine learning can be an invaluable tool in drug discovery for target identification, compound screening, and predictive modeling. The use of AI can accelerate drug discovery timelines, reduce costs and enhance therapeutic outcomes. 29 October 2024
Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.